Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca Rejigs Respiratory Franchise With Fresh Covis Deal
Licenses Out Eklira and Duaklir For $270m
Nov 01 2021
•
By
Kevin Grogan
• Source: Archive
More from Respiratory
More from Therapeutic Category